PEPTIDE MODULATORS OF ANGIOGENESIS AND USE THEREOF
    5.
    发明申请
    PEPTIDE MODULATORS OF ANGIOGENESIS AND USE THEREOF 有权
    生物发生的肽调节剂及其用途

    公开(公告)号:US20140100164A1

    公开(公告)日:2014-04-10

    申请号:US13962383

    申请日:2013-08-08

    IPC分类号: C07K14/575

    摘要: The invention generally features compositions and methods that are useful for modulating blood vessel formation, as well as methods that provide for the systematic and efficient identification of angiogenesis modulators. As described in more detail below, a systematic computational methodology based on bioinformatics was used to identify novel peptide modulators of angiogenesis that have been characterized in vitro and/or in vivo.

    摘要翻译: 本发明通常具有可用于调节血管形成的组合物和方法,以及提供血管新生调节剂的系统和有效鉴定的方法。 如下文更详细地描述的,使用基于生物信息学的系统计算方法来鉴定已在体外和/或体内表征的新型血管生成肽调节剂。

    Interferon-suppressing placental lactogen peptides
    7.
    发明申请
    Interferon-suppressing placental lactogen peptides 审中-公开
    干扰素抑制胎盘泌乳肽

    公开(公告)号:US20020032154A1

    公开(公告)日:2002-03-14

    申请号:US09876478

    申请日:2001-06-07

    发明人: John A. Peyman

    CPC分类号: C07K14/57518 A61K38/00

    摘要: Interferon-Suppressing Placental Lactogen Peptides (ISPLP) are disclosed which block actions of the human cytokine interferon-gamma. In addition, methods are disclosed for the treatment with ISPLP of certain disorders associated with increased expression of interferon-gamma-stimulated major histocompatibility complex antigens, such as autoimmune diseases, inflammatory diseases, and transplant rejection.

    摘要翻译: 公开了干扰素抑制胎盘乳糖肽(ISPLP),其阻断人细胞因子干扰素-γ的作用。 此外,公开了用于ISPLP治疗与干扰素-γ-刺激的主要组织相容性复合物抗原如自身免疫性疾病,炎性疾病和移植排斥反应增加相关的某些障碍的方法。